Dopamine Agonists: all 968 studies that test it
Page 9 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome SubjectsCompletedNCT00498108Phase 3
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral TabletsCompletedNCT00491998Phase 1/2
- ABLE: Abilify in Bipolar Disorder for Long-term EffectivenessCompletedNCT00484471Phase 4
- Low Dose Apomorphine and ParkinsonismWithdrawnNCT00472355Phase 2
- Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive BehaviorsCompletedNCT00471588Phase 1
- The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole TrialStatus unknownNCT00468533Phase 4
- A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac SurgeryCompletedNCT00467181Phase 2
- Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of RopiniroleCompletedNCT00460148Phase 2
- The Therapeutic Effect of Bromocriptin in Patients With Primary AldosteronismStatus unknownNCT00451672Phase 4
- Aripiprazole in the Treatment of Post-Traumatic Stress Disorder SymptomsCompletedNCT00440713Phase 3
- Cabergoline Reduces OHSSCompletedNCT00440258Phase 3
- Aripiprazole for the Treatment of Refractory AnxietyCompletedNCT00438386Phase 4
- Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)Status unknownNCT00437177Phase 2
- Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic NeuropathyCompletedNCT00432393Phase 4
- Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of FoodCompletedNCT00419692Phase 1
- An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.CompletedNCT00407095Phase 3
- SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsCompletedNCT00406588Phase 3
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
- Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of SchizophreniaStatus unknownNCT00395915Phase 4
- Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopaCompletedNCT00381472Phase 3
- Efficacy of Octreotide Acetate and Cabergoline in Patients With AcromegalyCompletedNCT00376064Phase 4
- A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLSCompletedNCT00375284Phase 4
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)CompletedNCT00374348Not applicable
- Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)CompletedNCT00367822Phase 3
- A Clinical Research Study Testing Ropinirole Treatment for Restless Legs SyndromeCompletedNCT00363857Phase 3
- A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar DepressionCompletedNCT00363337Phase 4
- Aripiprazole and Effexor XR Drug Interaction StudyCompletedNCT00362271Phase 1
- Aripiprazole and Lexapro Drug Interaction StudyCompletedNCT00361790Phase 1
- Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood DisturbancesCompletedNCT00356096Phase 4
- Long-Term Safety Of Ropinirole XR In Patients With Restless Legs SyndromeCompletedNCT00355641Phase 3
- A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLSCompletedNCT00349531Phase 4
- Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
- SWITCH:Restless Legs Patients Switched to Ropinirole From PramipexoleCompletedNCT00344994Phase 4
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeWithdrawnNCT00338273Phase 3
- An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsCompletedNCT00335374Phase 3
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Status unknownNCT00335205Phase 4
- Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to PlaceboCompletedNCT00334048Phase 4
- An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD PatientsCompletedNCT00332917Phase 3
- Effect on Cognitive Function of a Treatment With AripiprazoleCompletedNCT00329810Phase 4
- Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of QuinagolideCompletedNCT00329693Phase 2
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory SchizophreniaCompletedNCT00328367Phase 4
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.CompletedNCT00325689Phase 4
- Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I DisorderCompletedNCT00321516Phase 1
- Risperidone-Induced Hyperprolactinemia Treated With BromocriptineStatus unknownNCT00315081Phase 3
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of RopiniroleCompletedNCT00314860Phase 3
- Ropinirole in the Treatment of Bipolar DepressionCompletedNCT00314821Phase 4
- Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive ImpairmentStatus unknownNCT00306124Phase 4
- Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHDCompletedNCT00305370Phase 4
- Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)CompletedNCT00304655Phase 4
- SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic PatientsCompletedNCT00300846Phase 4
- A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric PracticesCompletedNCT00292409Phase 3
- Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
- Aripiprazole in the Treatment of Tourette's SyndromeTerminatedNCT00282139Not applicable
- Aripiprazole Augmentation Therapy in Treatment-resistant DepressionWithdrawnNCT00276978Phase 3
- Aripiprazole to Reduce Cocaine RelapseCompletedNCT00276874Phase 1
- Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) PatientsCompletedNCT00275457Phase 3
- A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00275236Phase 3
- SLV308 for Treatment of Patients With Early Parkinson's DiseaseCompletedNCT00269516Phase 3
- An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs SyndromeCompletedNCT00263068Phase 3
- Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's DiseaseStatus unknownNCT00260793Phase 3
- Study of Aripiprazole in Patients With Bipolar I DisorderCompletedNCT00257972Phase 3
- Fibromyalgia Study In AdultsCompletedNCT00256893Phase 2
- Pergolide for Cognitive Symptoms in Schizotypal Personality DisorderStatus unknownNCT00252044Not applicable
- Side Effects of Newer Antipsychotics in Older AdultsCompletedNCT00245206Phase 4
- Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on LevodopaCompletedNCT00244387Phase 3
- A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's DiseaseCompletedNCT00243971Phase 3
- A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's DiseaseCompletedNCT00243945Phase 3
- A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's DiseaseCompletedNCT00242008Phase 3
- Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's DiseaseCompletedNCT00240409Phase 3
- Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)CompletedNCT00239486Phase 2
- A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesCompletedNCT00237939Phase 3
- Schizophrenia Trial of AripiprazoleCompletedNCT00237913Phase 3
- Aripiprazole Treatment of Prodromal PatientsCompletedNCT00237874Phase 2/3
- A Switch Study of BMS-337039 in Schizophrenic Out-patientsCompletedNCT00232687Phase 4
- Effectiveness of Pramipexole for Treatment-Resistant DepressionCompletedNCT00231959Phase 4
- Aripiprazole in the Treatment of Bipolar DepressionCompletedNCT00226317Not applicable
- A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)CompletedNCT00225862Phase 3
- The Effects of Aripiprazole on Patients With Metabolic SyndromeCompletedNCT00224822Phase 4
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational SkillsCompletedNCT00223418Not applicable
- The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With SchizophreniaCompletedNCT00222833Phase 4
- Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)CompletedNCT00221962Phase 4
- An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar DisorderCompletedNCT00221416Phase 3
- Trial of Ropinirole in Motor Recovery After StrokeCompletedNCT00221390Phase 2
- Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine DependenceCompletedNCT00218075Phase 2
- Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent IndividualsTerminatedNCT00218049Phase 1
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)TerminatedNCT00211380Not applicable
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)TerminatedNCT00211302Not applicable
- Aripiprazole in Children With Autism: A Pilot StudyCompletedNCT00208533Phase 2
- Abilify Therapy for Reducing Comorbid Substance AbuseCompletedNCT00208169Phase 4
- Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons DiseaseCompletedNCT00200525Phase 3
- Continued Efficacy of Apomorphine After Previous Exposure of at Least Three MonthsCompletedNCT00200512Phase 2/3
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)CompletedNCT00200447Phase 2
- Aripiprazole Treatment of Bipolar DepressionCompletedNCT00198198Phase 4
- A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.CompletedNCT00198055Phase 2
- Ropinirole XR (Extended Release) In Patients With Restless Legs SyndromeCompletedNCT00197080Phase 3
- Aripiprazole in Late Life Bipolar DisorderCompletedNCT00194038Phase 4
- Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar DisorderCompletedNCT00181779Phase 4